SW-682 in Advanced Solid Tumors
Conditions
Advanced Solid Tumor · Mesothelioma, Malignant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
HonorHealth Research Institute, Scottsdale, Arizona, United States
Contact: Principal Investigator (Muhammad R Khawaja, MD)USC Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Contact: Principal Investigator (Diana Hanna, MD)UC San Diego Moores Cancer Center, Sacramento, California, United States
Contact: Principal Investigator (Sandip Patel, MD)UCLA Hematology-Oncology - Santa Monica, Santa Monica, California, United States
Contact: Principal Investigator (Arun S Singh, MD)University Hospital of Cleveland, Cleveland, Ohio, United States
Contact: Principal Investigator (Afshin Dowlati, MD)Oregon Health and Science University, Knight Cancer Institute - Marquam Hill, Portland, Oregon, United States
Contact: Principal Investigator (Shivaani Kummar)Mary Crowley Research Center US Oncology, Dallas, Texas, United States
Contact: Principal Investigator (Douglas Orr, MD)U.T. MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Timothy Yap, MD)
Study leads
Medical Responsible
Study Director
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany